Skip to main content
Log in

Fatal lactic acidosis and hypoglycemia in a patient with relapsed natural killer/T-cell lymphoma

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Presented here is the first reported case of natural killer (NK)/T-cell lymphoma associated with lactic acidosis (LA) and hypoglycemia. LA and hypoglycemia are rare complications of non-Hodgkin’s lymphoma. A 28-year-old male patient with NK/T-cell lymphoma had a relapse after 14 mo of initial remission and was admitted to the hospital because of altered mental status. He developed severe LA (pH, 7.17; lactate, 11.2 mmol/L) and hypoglycemia (42 mg/dL) that was resistant to sodium bicarbonate and glucose infusions. A very brief partial remission was achieved after a cycle of vincristine, dexamethasone, and L-asparaginase was given, but the disease recurred quickly after chemotherapy was discontinued and the patient did not respond to additional chemotherapy. The patient expired at 47 d after relapse. An extensive review of the literature reveals that only 2 of 28 patients have achieved complete remission, and more than 75% of patients died within 1 mo. Furthermore, 90% of previously reported cases had liver involvement. The case described here indicates that non-Hodgkin’s lymphoma-induced LA portends a poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.Am J Surg Pathol. 1999; 23: 1356–1369.

    Article  PubMed  CAS  Google Scholar 

  2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group.Blood. 1994; 84: 1361–1392.

    PubMed  CAS  Google Scholar 

  3. Jaffe ES, Chan JKC, Su U, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis and epidemiology.Am J Surg Pathol. 1996; 20: 103–111.

    Article  PubMed  CAS  Google Scholar 

  4. Jaffe ES, Harris NL, Diebold J, et al.WHO Classification of Tumors: Tumors of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001: 204–207.

    Google Scholar 

  5. Barnes L, Swerdlow S.Surgical Pathology of the Head and Neck. New York: Marcel Dekker, Inc.; 2001: 1307–1312.

    Google Scholar 

  6. Sillos EM, Shenep JL, Burghen GA, et al. Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature.Cancer. 2001; 92: 2237–2246.

    Article  PubMed  CAS  Google Scholar 

  7. Di Comite G, Dagna L, Piatti PM, et al. Hypoglycaemia and lactic acidosis in a MALT non-Hodgkin’s lymphoma.Leuk Lymphoma. 2002; 43: 1341–1342.

    PubMed  Google Scholar 

  8. Osorio S, Bernis C, de La Camara R. Lactic acidosis in non-Hodgkin’s lymphoma and response to chemotherapy.Haematologica. 2002; 87: 5.

    Google Scholar 

  9. Glasheen JJ, Sorensen MD. Burkitt’s lymphoma presenting with lactic acidosis and hypoglycemia — a case presentation.Leuk Lymphoma. 2005; 46: 281–283.

    Article  PubMed  Google Scholar 

  10. Dogan E, Erkoc R, Sayarlioglu H, et al. Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin’s lymphoma: case report.Adv Ther. 2005; 22: 443–446.

    PubMed  Google Scholar 

  11. Devita VT, Hellman S, Rosenberg SA.Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001: 2640–2642.

    Google Scholar 

  12. Narins RG, Krishna GG, Yee J, et al. The metabolic acidosis. In: Narins RG, ed.Maxwell & Kleeman’s Clinical Disorders of Fluid and Electrolyte Metabolism. 5th ed. New York, NY: McGraw-Hill, Inc.; 1994: 769–825.

    Google Scholar 

  13. Fields AL, Wolman SL, Halperin ML. Chronic lactic acidosis in a patient with cancer: therapy and metabolic consequences.Cancer. 1981; 47: 2026–2029.

    Article  PubMed  CAS  Google Scholar 

  14. Braunwald E, Fauci AS, Kasper DL, et al.Harrison’s Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill Professional; 2001: 723–724.

    Google Scholar 

  15. Abrahamian H, Pecherstorfer M, Vesely M, Baumgartner G, Irsigler K. Recurrent hypoglycemia and lactate acidosis in non-Hodgkin’s lymphoma [in German].Dtsch Med Wochenschr. 1991; 116: 1428–1432.

    PubMed  CAS  Google Scholar 

  16. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer.Adv Cancer Res. 1996; 68: 183–223.

    Article  PubMed  CAS  Google Scholar 

  17. Daughaday WH, Trivedi B, Baxter RC. Serum “big insulin-like growth factor II” from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.Proc Natl Acad Sci U S A. 1993; 90: 5823–5827.

    Article  PubMed  CAS  Google Scholar 

  18. Goodgame JT Jr, Pizzo P, Brennan MF. Iatrogenic lactic acidosis: association with hypertonic glucose administration in a patient with cancer.Cancer. 1978; 42: 800–803.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bing Hu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

He, YF., Wei, W., Sun, ZM. et al. Fatal lactic acidosis and hypoglycemia in a patient with relapsed natural killer/T-cell lymphoma. Adv Therapy 24, 505–509 (2007). https://doi.org/10.1007/BF02848772

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02848772

Keywords

Navigation